• Clinical Evidence

Safety of EndoTool Versus Fixed-Dose Insulin Infusions for DKA or HHS in the Emergency Department

Setting: 433-bed not-for-profit acute care hospital

Objective

This retrospective study compares the safety of EndoTool glucose management software to a standard fixed-dose insulin infusion protocol for patients presenting to an emergency department with DKA or HHS.

Setting

433-bed not-for-profit acute care hospital.

Results

  • Incidence of hypoglycemia <70 mg/dL was 0.00% of patients with EndoTool versus 4.7% with a standard fixed-dose insulin infusion protocol.

Conclusions

Titration of insulin using glucose management software (EndoTool) may be safer than a standard fixed-dose insulin infusion protocol for patients presenting in an emergency department with DKA or HHS, as evidenced by significantly lower incidence of hypoglycemia.
Objective

This retrospective study compares the safety of EndoTool glucose management software to a standard fixed-dose insulin infusion protocol for patients presenting to an emergency department with DKA or HHS.

Setting

433-bed not-for-profit acute care hospital.

Results
  • Incidence of hypoglycemia <70 mg/dL was 0.00% of patients with EndoTool versus 4.7% with a standard fixed-dose insulin infusion protocol.
Conclusions

Titration of insulin using glucose management software (EndoTool) may be safer than a standard fixed-dose insulin infusion protocol for patients presenting in an emergency department with DKA or HHS, as evidenced by significantly lower incidence of hypoglycemia.

References

Authors

Meghin Moynihan, PharmD; Brandon Powell, PharmD, BCCCP; Ginger Barrick, PharmD, MSCR, BCPS; Kalynn Northam, PharmD, BCCCP.

Source

Presented at Society of Critical Care Medicine Critical Care Congress. Published in Critical Care Medicine, Volume 50, Issue 1, p605.

Year

2022

Quick navigation
Objective
Setting
Results
Conclusions
References
Objective

This retrospective study compares the safety of EndoTool glucose management software to a standard fixed-dose insulin infusion protocol for patients presenting to an emergency department with DKA or HHS.

Setting

433-bed not-for-profit acute care hospital.

Results
  • Incidence of hypoglycemia <70 mg/dL was 0.00% of patients with EndoTool versus 4.7% with a standard fixed-dose insulin infusion protocol.
Conclusions

Titration of insulin using glucose management software (EndoTool) may be safer than a standard fixed-dose insulin infusion protocol for patients presenting in an emergency department with DKA or HHS, as evidenced by significantly lower incidence of hypoglycemia.

References

Authors

Meghin Moynihan, PharmD; Brandon Powell, PharmD, BCCCP; Ginger Barrick, PharmD, MSCR, BCPS; Kalynn Northam, PharmD, BCCCP.

Source

Presented at Society of Critical Care Medicine Critical Care Congress. Published in Critical Care Medicine, Volume 50, Issue 1, p605.

Year

2022

Short and Sweet Headlines are Best!

Related posts

Image
  • Clinical Evidence

Temple Health Achieves Zero Severe Hypoglycemia in Renally Impaired Patients with EndoTool SubQ

Temple Health Achieves Zero Severe Hypoglycemia in Renally Impaired Patients with EndoTool SubQ

To evaluate the safety and efficacy of the EndoTool SubQ (ETSQ) insulin dosing application for subcutaneous (SQ) insulin administration in hospitalized patients, and to compare clinical outcomes against those treated using a standard insulin order set. The analysis also examined performance in high-risk patients with advanced renal impairment.
Image
  • Clinical Evidence

Improving Inpatient Glycemic Safety at Temple Health with EndoTool SubQ

Improving Inpatient Glycemic Safety at Temple Health with EndoTool SubQ

Temple Health, a 3-hospital academic system was experiencing high rates of hypoglycemia due to reliance on sliding scale insulin (SSI). To improve safety and align with ADA guidelines, the hospital implemented EndoTool SubQ, a patient-specific insulin dosing software the supports four dosing protocols, including basal-bolus-correction (BBC).
Image
  • Clinical Evidence

How Corewell Health Reduced LOS for DKA Patients, Slashing Costs by Almost $1M

How Corewell Health Reduced LOS for DKA Patients, Slashing Costs by Almost $1M

The objective of this study was to evaluate the impact of EndoTool IV insulin dosing software on mortality, length of stay, readmission rates, and cost of care for patients treated for Diabetic Ketoacidosis (DKA) at Corewell Health West.
Get in Touch

Ready to get started?

Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*